Recruiting NA Autism Spectrum Disorder

Tests treatment safety and results for Autism Spectrum Disorder

Official title Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)

ClinicalTrials.gov ID: NCT07258914

What this study is testing

What it's testing
Depression is a common complication of Autism Spectrum Disorder (ASD): it is four times more prevalent in people with ASD than in the general population. However, treating depression in people with ASD is complicated by the lack of guidelines.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • Patient with a diagnosis of ASD validated by a psychiatrist or line 2
  • Patient aged 18 to 65...
  • Patients suffering from EDM (MADRS greater than 20)
  • No change in treatment in the month prior to inclusion
  • Patients affiliated with or entitled to social security

You likely can't join if

  • Patients with psychiatric comorbidity (decompensated manic state, schizophrenic disorder)
  • Pregnancy at the time of inclusion
  • Patients with contraindications to rTMS and MRI (history of epilepsy, neurological stimulator, pacemaker, cardiac defibrillator, cardiac prosthesis...
  • Adults under legal protection (legal guardianship, curatorship, trusteeship), persons deprived of their liberty, persons hospitalised under...
See the full eligibility criteria
Who can join
  • Patient with a diagnosis of ASD validated by a psychiatrist or line 2
  • Patient aged 18 to 65...
  • Patients suffering from EDM (MADRS greater than 20)
  • No change in treatment in the month prior to inclusion
  • Patients affiliated with or entitled to social security
  • Patients who have received informed information about the study and have signed a consent form to participate in the study
What rules you out
  • Patients with psychiatric comorbidity (decompensated manic state, schizophrenic disorder)
  • Pregnancy at the time of inclusion
  • Patients with contraindications to rTMS and MRI (history of epilepsy, neurological stimulator, pacemaker, cardiac defibrillator, cardiac prosthesis, vascular prosthesis, intracranial clips or clamps, cerebrospinal fluid...
  • Adults under legal protection (legal guardianship, curatorship, trusteeship), persons deprived of their liberty, persons hospitalised under compulsion (SDT, SDRE).

The study team makes the final eligibility decision.

Where it's taking place

  • Rennes, France

Compensation & support

A stipend or compensation may be offered.

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Rennes, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.